A multicenter random assignment phase II study of irinotecan and flavopiridol versus irinotecan alone for patients with p53 wild-type gastric adenocarcinoma (NCI 8060) Meeting Abstract


Authors: Shah, M. A.; Smyth, E. C.; Shibata, S.; Yong, W.; Tang, L. H.; Janjigian, Y. Y.; Kelsen, D. P.; Schwartz, G. K.
Abstract Title: A multicenter random assignment phase II study of irinotecan and flavopiridol versus irinotecan alone for patients with p53 wild-type gastric adenocarcinoma (NCI 8060)
Meeting Title: 46th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 28
Issue: 15 Suppl.
Meeting Dates: 2010 Jun 4-8
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2010-05-20
Start Page: 33s
Language: English
ACCESSION: WOS:000208852002209
DOI: 10.1200/jco.2010.28.15_suppl.tps209
PROVIDER: wos
Notes: Meeting Abstract: TPS209 -- S -- Source: Wos
Altmetric Score
MSK Authors
  1. Gary Schwartz
    358 Schwartz
  2. Yelena Yuriy Janjigian
    145 Janjigian
  3. Elizabeth Catherine Smyth
    19 Smyth
  4. Manish Shah
    174 Shah
  5. Laura Hong Tang
    320 Tang
  6. David P Kelsen
    332 Kelsen